Clinical

Dataset Information

0

A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies


ABSTRACT: To evaluate the safety, tolerability, efficacy, and pharmacokinetics of MDX-1106 when administered to patients with advanced non-small cell lung cancer, colorectal cancer, malignant melanoma, clear cell renal cell cancer or hormone refractory prostate cancer

DISEASE(S): Adenocarcinoma,Kidney Neoplasms,Carcinoma,Lung Cancer,Melanoma,Colorectal Cancer,Malignant Melanoma,Neoplasms,Prostatic Neoplasms,Carcinoma, Renal Cell,Renal Cancer,Colorectal Neoplasms,Carcinoma, Non-small-cell Lung,Prostate Cancer,Cancer

PROVIDER: 2037574 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2022-12-31 | GSE193382 | GEO
2011-09-28 | E-GEOD-32474 | biostudies-arrayexpress
2011-06-16 | E-GEOD-29682 | biostudies-arrayexpress
2008-06-14 | E-GEOD-5720 | biostudies-arrayexpress
2011-06-12 | E-GEOD-29288 | biostudies-arrayexpress
2008-06-15 | E-GEOD-5949 | biostudies-arrayexpress
2005-11-23 | E-TABM-65 | biostudies-arrayexpress
2012-02-01 | GSE32264 | GEO
2011-09-29 | GSE32474 | GEO
2011-06-17 | GSE29682 | GEO